Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP998674.RAaQC_6ffxe7-2_dYcSFHm0a2BQbVPFRomR9U6RQk4aDE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP998674.RAaQC_6ffxe7-2_dYcSFHm0a2BQbVPFRomR9U6RQk4aDE130_assertion type Assertion NP998674.RAaQC_6ffxe7-2_dYcSFHm0a2BQbVPFRomR9U6RQk4aDE130_head.
- NP998674.RAaQC_6ffxe7-2_dYcSFHm0a2BQbVPFRomR9U6RQk4aDE130_assertion description "[A better understanding of MET-miR-221 and 222 axis regulation in drug resistance is the key in developing new strategies in NSCLC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP998674.RAaQC_6ffxe7-2_dYcSFHm0a2BQbVPFRomR9U6RQk4aDE130_provenance.
- NP998674.RAaQC_6ffxe7-2_dYcSFHm0a2BQbVPFRomR9U6RQk4aDE130_assertion evidence source_evidence_literature NP998674.RAaQC_6ffxe7-2_dYcSFHm0a2BQbVPFRomR9U6RQk4aDE130_provenance.
- NP998674.RAaQC_6ffxe7-2_dYcSFHm0a2BQbVPFRomR9U6RQk4aDE130_assertion SIO_000772 21706050 NP998674.RAaQC_6ffxe7-2_dYcSFHm0a2BQbVPFRomR9U6RQk4aDE130_provenance.
- NP998674.RAaQC_6ffxe7-2_dYcSFHm0a2BQbVPFRomR9U6RQk4aDE130_assertion wasDerivedFrom befree-20150227 NP998674.RAaQC_6ffxe7-2_dYcSFHm0a2BQbVPFRomR9U6RQk4aDE130_provenance.
- NP998674.RAaQC_6ffxe7-2_dYcSFHm0a2BQbVPFRomR9U6RQk4aDE130_assertion wasGeneratedBy ECO_0000203 NP998674.RAaQC_6ffxe7-2_dYcSFHm0a2BQbVPFRomR9U6RQk4aDE130_provenance.